Implementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya
Authors:
- André TrollipATAndré Trollip
- Renuka GaddeRGRenuka Gadde
- Tjeerd DatemaTDTjeerd Datema
- Kamau GatwechiKGKamau Gatwechi
- Linda OskamLOLinda Oskam
- Zachary KatzZKZachary Katz
- Andrew WhitelawAWAndrew Whitelaw
- Peter KinyanjuiPKPeter Kinyanjui
- Patrick NjukengPNPatrick Njukeng
- Dawit A. WendifrawDWDawit A. Wendifraw
- Ibrahimm MugerwaIMIbrahimm Mugerwa
- Grace NajjukaGNGrace Najjuka
Open Access
- 31 January 2022
- journal article
- research article
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 1476
Abstract
Background: In low-resource settings, antimicrobial resistance (AMR) is detected by traditional culture-based methods and ensuring the quality of such services is a challenge. The AMR Scorecard provides laboratories with a technical assessment tool for strengthening the quality of bacterial culture, identification, and antimicrobial testing procedures.Objective: To evaluate the performance of the AMR Scorecard in 11 pilot laboratory evaluations in three countries also assessed with the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) checklist.Methods: Pilot laboratory evaluations were conducted in Cameroon, Ethiopia and Kenya between February 2019 and March 2019. Assessors with previous SLIPTA and microbiology experience were trained. Assessors performed the laboratory assessments using the SLIPTA and AMR Scorecard tools.Results: Weaknesses in technical procedures and the quality management systems were identified in all areas and all laboratories. Safety had the highest mean performance score (SLIPTA: 68%; AMR Scorecard: 73%) while management review had the lowest (SLIPTA: 32%; AMR Scorecard: 8%) across all laboratories. The AMR Scorecard scores were generally consistent with SLIPTA scores. The AMR Scorecard identified technical weaknesses in AMR testing, and SLIPTA identified weaknesses in the quality management systems in the laboratories.Conclusion: Since the AMR Scorecard identified important gaps in AMR testing not detected by SLIPTA, it is recommended that microbiology laboratories use SLIPTA and the AMR Scorecard in parallel when preparing for accreditation. Expanding the use of the AMR Scorecard is a priority to address the need for quality clinical microbiology laboratory services in support of optimal patient care and AMR surveillance.Keywords
This publication has 23 references indexed in Scilit:
- The SLMTA programme: Transforming the laboratory landscape in developing countriesAfrican Journal of Laboratory Medicine, 2014
- Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic reviewJournal of Antimicrobial Chemotherapy, 2014
- Strengthening national health laboratories in sub‐Saharan Africa: a decade of remarkable progressTropical Medicine & International Health, 2014
- Measurement of Improvement Achieved by Participation in International Laboratory Accreditation in Sub-Saharan AfricaAmerican Journal of Clinical Pathology, 2014
- Impact of mentorship on WHO-AFRO Strengthening Laboratory Quality Improvement Process Towards Accreditation (SLIPTA)African Journal of Laboratory Medicine, 2011
- Impact of Laboratory Accreditation on Patient Care and the Health SystemAmerican Journal of Clinical Pathology, 2010
- Improving Quality Management Systems of Laboratories in Developing CountriesAmerican Journal of Clinical Pathology, 2010
- The World Health Organization African Region Laboratory Accreditation ProcessAmerican Journal of Clinical Pathology, 2010
- Medical Microbiology: Assuring the Quality of Clinical Microbiology Test ResultsClinical Infectious Diseases, 2008
- Laboratory Medicine in Africa: A Barrier to Effective Health CareClinical Infectious Diseases, 2006